 |
 |

Clinical and Biochemical Effects of Catecholamine Depletion on Antidepressant-Induced Remission of Depression
Heien L. Miller, MD;
Pedro L. Delgado, MD;
Ronald M. Salomon;
Robert Berman, MD;
John H. Krystal, MD;
George R. Heninger, MD;
Dennis S. Charney, MD
Arch Gen Psychiatry. 1996;53(2):117-128.
Abstract
 |  |
Background Most hypotheses of the therapeutic mechanism of action of antidepressant drugs have focused on the role of the monoamines. We examined the effect of catecholamine depletion on antidepressant-induced remission.
Method The tyrosine hydroxylase inhibitor ct-methylparatyrosine and the antihistamine diphenhydramine hydrochloride were administered, during separate test sessions, to depressed patients in remission maintained with either norepinephrine reuptake inhibitors (desipramine [n=7] ormazindol [n=2]) or serotonin reuptake inhibitors (fluoxetine hydrochloride [n=9] or sertraline hydrochloride [n=l]). Because of considerable sedation associated with -methylparatyrosine testing, diphenhydramine was used as an active control rather than an inactive placebo. The effects of -methylparatyrosine and diphenhydramine on depression, anxiety, and plasma catecholamine metabolites were assessed.
Results
-Methylparatyrosine produced similar significant decreases in plasma 3-methoxy-4-hydroxyphenyl-ethyleneglycol and homovanillic acid levels in the treatment groups. a-Methylparatyrosine produced a robust increase in depressive symptoms on the Hamilton Depression Rating Scale, including depressed mood, decreased concentration, anhedonia, loss of interest, and feelings of worthlessness, helplessness, and hopelessness, in the desipramine-mazindol but not in the fluoxetine-sertraline group. Diphenhydramine had no effects on mood in either treatment group.
Conclusions The therapeutic effects of norepinephrine reuptake inhibitors, but not serotonin reuptake inhibitors, are reversed by catecholamine depletion. Considered with previous reports that serotonin depletion produces depressive relapses in patients in remission maintained with serotonin reuptake inhibitors, but not norepinephrine reuptake inhibitors, these findings suggest that antidepressants may not work via a single monoamine-related mechanism.
Author Affiliations
From the Department of Psychiatry, Yale University School of Medicine, New Haven, Conn, and the Department of Veterans Affairs Medical Center, West Haven, Conn.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Neural Response to Catecholamine Depletion in Unmedicated Subjects With Major Depressive Disorder in Remission and Healthy Subjects
Hasler et al.
Arch Gen Psychiatry 2008;65:521-531.
ABSTRACT
| FULL TEXT
The Role of Dopamine in the Pathophysiology of Depression
Dunlop and Nemeroff
Arch Gen Psychiatry 2007;64:327-337.
FULL TEXT
Antidepressant-Induced Increase in High-Affinity Rolipram Binding Sites in Rat Brain: Dependence on Noradrenergic and Serotonergic Function
Zhao et al.
J. Pharmacol. Exp. Ther. 2003;307:246-253.
ABSTRACT
| FULL TEXT
Regional Brain Metabolic Correlates of {alpha}-Methylparatyrosine-Induced Depressive Symptoms: Implications for the Neural Circuitry of Depression
Bremner et al.
JAMA 2003;289:3125-3134.
ABSTRACT
| FULL TEXT
The hypocretin/orexin system
Ebrahim et al.
JRSM 2002;95:227-230.
FULL TEXT
Use of Dopamine-beta -hydroxylase-Deficient Mice to Determine the Role of Norepinephrine in the Mechanism of Action of Antidepressant Drugs
Cryan et al.
J. Pharmacol. Exp. Ther. 2001;298:651-657.
ABSTRACT
| FULL TEXT
Tryptophan depletion and its implications for psychiatry
BELL et al.
Br. J. Psychiatry 2001;178:399-405.
ABSTRACT
| FULL TEXT
Transient Depressive Relapse Induced by Catecholamine Depletion: Potential Phenotypic Vulnerability Marker?
Berman et al.
Arch Gen Psychiatry 1999;56:395-403.
ABSTRACT
| FULL TEXT
Effects of Tryptophan Depletion vs Catecholamine Depletion in Patients With Seasonal Affective Disorder in Remission With Light Therapy
Neumeister et al.
Arch Gen Psychiatry 1998;55:524-530.
ABSTRACT
| FULL TEXT
A Molecular and Cellular Theory of Depression
Duman et al.
Arch Gen Psychiatry 1997;54:597-606.
ABSTRACT
Decreased Serotonin Function in Bulimia Nervosa
Jimerson et al.
Arch Gen Psychiatry 1997;54:529-534.
ABSTRACT
Effects of Tryptophan Depletion on Drug-Free Patients With Seasonal Affective Disorder During a Stable Response to Bright Light Therapy
Neumeister et al.
Arch Gen Psychiatry 1997;54:133-138.
ABSTRACT
|